Publications by authors named "Tomomi Hashiba"

Claim this Profile
E
Evaluation of Long-Read RNA Sequencing Procedures for Novel Isoform Identification and Quantification in Human Whole Blood.
Hikari Okada, Alessandro Nasti, Yoshio Sakai, Yumie Takeshita, Sadahiro Iwabuchi, Tomomi Hashiba

Genes (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
Yoshiro Asahina, Hajime Takatori, Kouki Nio, Hikari Okada, Takehiro Hayashi, Tomomi Hashiba

Int J Mol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.
Tomomi Hashiba, Taro Yamashita, Hikari Okada, Kouki Nio, Takehiro Hayashi

Cell Mol Gastroenterol Hepatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer.
Tatsuo Kumai, Eishiro Mizukoshi, Tomomi Hashiba, Hidetoshi Nakagawa, Masaaki Kitahara

Cytotherapy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer.
Miyabi Miura, Eishiro Mizukoshi, Tomomi Hashiba, Masaaki Kitahara, Tomoharu Miyashita

Cancer Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
Tomoyuki Hayashi, Taro Yamashita, Hikari Okada, Naoki Oishi, Hajime Sunagozaka, Tomomi Hashiba

Anticancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De Novo Emergence of Mesenchymal Stem-Like CD105 Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma.
Yoshimoto Nomura, Taro Yamashita, Naoki Oishi, Kouki Nio, Takehiro Hayashi, Tomomi Hashiba

Transl Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSU-68 ameliorates hepatocellular carcinoma growth by inhibiting microenvironmental platelet-derived growth factor signaling.
Yasumasa Hara, Taro Yamashita, Naoki Oishi, Kouki Nio, Takehiro Hayashi, Tomomi Hashiba

Anticancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis